This Article Abstract Full Text (PDF) All Versions of this Article: 42/2/195    most recent 01.HYP.0000081221.36703.01v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Komlosi, P. Articles by Bell, P. D. Search for Related Content PubMed PubMed Citation Articles by Komlosi, P. Articles by Bell, P. D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CAPTOPRIL SODIUM Related Collections ACE/Angiotension receptors

(Hypertension. 2003;42:195.)
© 2003 American Heart Association, Inc.

Scientific Contributions

Angiotensin I Conversion to Angiotensin II Stimulates Cortical Collecting Duct Sodium Transport

Peter Komlosi; Amanda L. Fuson; Attila Fintha; János Peti-Peterdi; Laszlo Rosivall; David G. Warnock; Phillip Darwin Bell

From the Departments of Medicine and Physiology, Division of Nephrology, University of Alabama at Birmingham (P.K., A.L.F., A.F., J.P.-P., D.G.W., P.D.B.), and the Institute of Pathophysiology, Hungarian Academy of Sciences and Semmelweis University Nephrology Research Group (P.K., A.F., J.P.-P., L.R.), Budapest, Hungary.

Correspondence to Phillip Darwin Bell, 865 Sparks Center, 1720 Seventh Ave South, Birmingham, AL 35294. E-mail pdbell{at}uab.edu

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Angiotensin (Ang) II directly stimulates epithelial sodium channel activity in the rabbit cortical collecting duct. Because Ang I and converting enzyme analogues might be present in the distal nephron, this raises the possibility of intraluminal generation of Ang II. Conversion of Ang I to Ang II was monitored by Ang II–dependent changes in intracellular sodium concentration as a reflection of sodium transport across the apical membrane. This involved imaging-based fluorescence microscopy with sodium-binding benzofuran isophthalate in isolated, perfused, cortical collecting-duct segments from rabbit kidney. Principal and intercalated cells were differentiated by rhodamine-conjugated peanut lectin. Control principal cell intracellular sodium concentration, during perfusion with 25 mmol/L NaCl and zero sodium in the bath plus monensin (10^-5 mol/L) averaged 5.8±0.14 mmol/L (n=156). The increase in intracellular sodium concentration, when luminal NaCl was increased from 25 to 150 mmol/L, was elevated by 3.5-fold in the presence of intraluminal Ang I (10^-6 mol/L). Also, the effects of Ang I on sodium transport were not significantly different from the effects of Ang II (10^-9 mol/L). Ang I was used in micromolar concentrations to ensure that there was sufficient substrate available for conversion to Ang II. Inhibition of the angiotensin-converting enzyme with captopril reduced the stimulatory effect of Ang I. These results suggest that intraluminal conversion of Ang I to Ang II can occur in the cortical collecting duct, resulting in enhanced apical sodium entry.

Key Words: angiotensin-converting enzyme • imaging • kallikrein • kidney • rabbits • renin-angiotensin system

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
The renin-angiotensin system (RAS) functions as both a circulating endocrine and a tissue paracrine system. As an endocrine peptide, angiotensin (Ang) II exerts a prominent influence on blood pressure control and body fluid and electrolyte balance, whereas as a locally formed paracrine peptide, it is involved in the regulation of regional hemodynamics, tissue remodeling, neurotransmitter release, cell growth, and ion transport.¹ In the kidney, besides its role in the juxtaglomerular apparatus, accumulating evidence indicates the importance of intratubular RAS in the control of salt and water transport. In addition to the presence of a fully functional RAS in the proximal tubule,² there is evidence that Ang II can also be formed in the distal nephron.³ Angiotensinogen, which is produced and secreted by the proximal tubule, traverses the nephron to the connecting tubule. At this site, renin, which is secreted into the distal tubular fluid, cleaves angiotensinogen, forming Ang I. Because of technical difficulties, it has not been possible to obtain precise measurements of Ang II and its precursors in the distal nephron. However, indirect data suggest that tubular Ang I concentration is much higher than in plasma.⁴

Recent studies have demonstrated the existence of alternative Ang II–forming pathways, in addition to angiotensin-converting enzyme (ACE). Serine proteases, such as chymase⁵ and glandular kallikrein,⁶ are candidates responsible for ACE-independent Ang II formation in the heart. The existence and level of expression of Ang II–forming enzymes differ markedly among species and organs. In rabbit kidney, aprotinin-inhibitable kallikrein has been localized to the distal nephron, including the first part of the cortical collecting duct (CCD).^7,8 Kallikrein appears to be located at the apical membrane, with its catalytic active site directed into the lumen.⁹ ACE was also demonstrated to be secreted into the tubular lumen of the collecting duct,¹⁰ where its suggested role was in kinin hydrolysis.¹¹

Along with its effects on proximal tubular transport, Ang II has been shown to act on various ion channels and transporters in the CCD.^12–14 Ang II was suggested to stimulate amiloride-sensitive Na⁺ channels in the initial part of the collecting tubule.¹⁵ Previous work from our laboratory has shown that Ang II, added to luminal fluid, exerts a direct stimulatory effect on the epithelial sodium channel (ENaC) in the rabbit CCD.¹⁶ In the current studies, we hypothesized that the various proteinases present in the tubular cells and/or tubular fluid might convert Ang I to Ang II in the lumen of the CCD, thereby resulting in an Ang II–mediated increase in ENaC activity.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Materials
All materials were purchased from Sigma unless otherwise stated.

Tubule Perfusion
We isolated and perfused individual CCD segments dissected from rabbit (New Zealand, Myrtle’s Rabbitry, Thompson Station, Tenn; 800 to 1000 g body weight, n=37 animals) kidneys as described previously.¹⁶ This preparation allowed us to manipulate the composition of the tubular fluid at the apical side (perfusate) independently from the basolateral interstitium (bath). The dissection solution was composed of (in mmol/L) 25 NaCl, 125 N-methyl-D-glucamine cyclamate, 5 KCl, 1 MgSO₄, 1.6 Na₂HPO₄, 0.4 NaH₂PO₄, 1.5 CaCl₂, 5 D-glucose, and 10 HEPES and was adjusted to a pH of 7.4. Tubules (0.8 to 1.2 mm long) were bathed and perfused with this same solution. For the experiments, CCDs were bathed in a modified solution in which NaCl was isosmotically replaced with N-methyl-D-glucamine cyclamate to achieve an NaCl concentration of 0 mmol/L and containing the Na⁺ ionophore monensin (10^-5 mol/L). This maneuver effectively eliminated the basolateral membrane as a barrier for Na⁺ movement, and the absence of bath Na⁺ resulted in a lowering of principal cell intracellular sodium concentration ([Na⁺]_i). Under these conditions, Na⁺ entry across the apical membrane is the only means of altering [Na⁺]_i, and because changes in [Na⁺]_i are blocked with luminal benzamyl, this strongly suggests that what we are measuring is a reflection of apical entry via the ENaC. Also, in our model, the reduced [Na⁺]_i, which was achieved by elimination of bath Na⁺ and addition of monensin, most likely reduced or eliminated the high [Na⁺]_i-induced feedback inhibition of ENaC activity that is found when Na⁺ transport is elevated in intact cells.

Fluorescence Microscopy
[Na⁺]_i in CCD cells was measured with imaging-based, dual-excitation-wavelength fluorescence microscopy with use of the fluorescent probe sodium-binding benzofuran isophthalate (SBFI, Teflabs). After cannulation, tubules were loaded with 5x10^-6 mol/L of the acetoxymethyl ester of SBFI added to the luminal perfusate. Studies were performed in a chamber mounted on an inverted epifluorescence microscope (Eclipse TE2000, Nikon), which was linked to a cooled charge-coupled-device camera (SenSys, Photometrics) interfaced with a digital imaging system (Photon Technologies, Inc). To identify principal and intercalated cells, we labeled intercalated cells by adding rhodamine-labeled peanut lectin (PNA, Vector Labs) to the luminal perfusate for 5 minutes and observed which cells were fluorescent with excitation and emission wavelengths of 545 and 620 nm, respectively.¹⁷ SBFI fluorescence ratios (340/380 nm) were converted to [Na⁺]_i values, as described previously.¹⁸ Two to 4 cells were analyzed in each CCD preparation, and 2 or 3 preparations were used from each animal.

Immunofluorescence
Rabbit kidneys were perfusion-fixed with paraformaldehyde, and tissue sections were processed as described earlier.¹⁹ After subsequent washings in phosphate-buffered saline, tissues were treated with a goat polyclonal ACE-1 antibody (C-20, 1:100, Santa Cruz Biotechnology) for 1 hour. This was followed by incubation with Alexa594-conjugated donkey anti-goat immunoglobulin G (1:500, Molecular Probes) for 40 minutes. Sections were mounted with an appropriate medium (Vectashield) containing 4,6-diamino-2-phenylindole for nuclear staining (Vector Labs). Tissue sections were examined with an inverted epifluorescence microscope (IX70, Olympus) equipped with a UApo/340 40x objective. Images were captured with the digital camera described previously (SenSys) and IPLab Spectrum software (Signal Analytics Corp).

Statistical Analyses
Data are expressed as mean±SE. Statistical significance was tested by ANOVA. Significance was defined as P<0.05.

	Results

Top Abstract Introduction Methods Results Discussion References

 
Control and Ang II–Facilitated [Na⁺]_i Transport
As shown in Figure 1A, principal and intercalated cells were differentiated by selective, apical, PNA binding. After removal of basolateral NaCl and permeabilization of the basolateral membrane with the Na⁺ ionophore monensin (10^-5 mol/L), steady-state [Na⁺]_i did not differ between principal and intercalated cells (5.8±0.14 vs 5.7±0.16 mmol/L; n=156 and 154, respectively) during perfusion with 25 mmol/L luminal NaCl concentration ([NaCl]_L). Representative recordings in Figures 1B and 1C illustrate that increasing [NaCl]_L from 25 to 150 mmol/L caused rapid and sustained elevations in both principal and intercalated cell [Na⁺]_i. This increase in principal cell [Na⁺]_i was elevated by 3.5-fold in the presence of luminal Ang II (10^-9 mol/L); however, there was no effect of Ang II on sodium transport in intercalated cells.

View larger version (33K): [in this window] [in a new window]   Figure 1. A, Overlay of light microscopic and fluorescence images of an isolated, perfused CCD, showing selective apical binding of rhodamine-conjugated PNA (red) in intercalated cells. Squares show the region of interest (photometer windows) for principal (PC) and intercalated (IC) cells. B and C, Representative recordings of the effects of increasing luminal [NaCl] from 25 to 150 mmol/L on [Na+]i in the presence of Ang II (10-9 mol/L) or Ang I (10-6 mol/L) in the principal and intercalated cells of rabbit CCD, respectively.

Effect of Ang I
Ang I (10^-6 mol/L) added to the luminal perfusate increased [Na⁺]_i in principal cells by 3.5-fold when [NaCl]_L was increased from 25 to 150 mmol/L (Figures 1B and 2). Thus, the effects of micromolar Ang I on Na⁺ transport were nearly identical to those found with nanomolar Ang II. This increase in [Na⁺]_i responses with Ang I was almost completely abolished by luminal addition of 10^-7 mol/L benzamyl, a specific inhibitor of ENaC. Also, coadministration of luminal Ang I with the Ang II type 1 (AT₁) receptor blocker losartan (10^-6 mol/L) reduced the stimulatory effects of Ang I on [Na⁺]_i in principal cells to a level not significantly different from control (Figure 2).

View larger version (24K): [in this window] [in a new window]   Figure 2. Effects of luminal Ang II (10-9 mol/L) or Ang I (10-6 mol/L) on the 150 mmol/L luminal [NaCl]-induced elevation in [Na+]i in rabbit principal cells. Also shown are the effects of Ang I in the presence of the specific ENaC blocker benzamyl (10-7 mol/L) or the AT1 receptor blocker losartan (10-6 mol/L). n=14; *P<0.05 compared with control.

ACE Blockade
In principal cells, addition of the ACE inhibitor captopril (10^-4 mol/L) or the protease inhibitor aprotinin (10^-5 mol/L) to the luminal perfusate blocked the Ang I–induced [Na⁺]_i responses by 50% (Figure 3A). Coadministration of both drugs plus Ang I attenuated the increases in [Na⁺]_i by 85% in response to an elevation in [NaCl]_L compared with Ang I alone, although this inhibition was not statistically different from the inhibition obtained with either captopril or aprotinin alone. Various controls were performed to determine the specificity of our observations. First, in PNA-positive intercalated cells, with or without inhibitors, Ang I did not alter the magnitude of increase in [Na⁺]_i in response to an elevation in [NaCl]_L (Figure 3B). Second, captopril plus aprotinin had no significant effect on Ang II stimulation of [Na⁺]_i responses (Figure 4) in principal cells. This eliminates the possibility that the effects of these agents to inhibit Ang I–mediated increases in [Na⁺]_i responses were due to some nonspecific action of these drugs. Third, in the presence of captopril and aprotinin and either Ang I or Ang II, [Na⁺]_i responses with elevations in [NaCl]_L were the same as in controls in the presence of losartan, the AT₁ receptor blocker (data not shown). Fourth, captopril and aprotinin in the absence of Ang I did not significantly alter [Na⁺]_i responses (data not shown).

View larger version (15K): [in this window] [in a new window]   Figure 3. Effects of luminal ACE blocker captopril (10-4 mol/L) and/or glandular kallikrein blocker aprotinin (10-5 mol/L) on [Na+]i in the presence of Ang I (10-6) during elevations in [NaCl]L from 25 to 150 mmol/L in principal (A) and intercalated (B) cells. n=14; *P<0.05 compared with Ang I alone.

View larger version (26K): [in this window] [in a new window]   Figure 4. Effects of luminal captopril and aprotinin on Ang I- or Ang II-stimulated [Na+]I responses in principal cells. n=14; *P<0.05 compared with Ang I or Ang II alone.

Immunofluorescence Labeling of ACE-1
Figure 5 shows ACE-1 labeling within the collecting duct at the corticomedullary boundary in rabbit kidney, with strong labeling at the apical membrane and cytoplasm. At more cortical segments, the apical staining was less prominent.

View larger version (69K): [in this window] [in a new window]   Figure 5. A, Immunofluorescence labeling of ACE-1 (red) in rabbit kidney. Intense apical and cytoplasmic staining was seen in collecting ducts (arrowhead) at the niveau of the corticomedullary transition. B, Absence of staining in the same segment, with omission of primary antibody. Nuclei are blue. Bar=20 µm.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
The present studies were designed to determine whether intratubular Ang II generation from Ang I occurs in the distal nephron. We measured changes in [Na⁺]_i by using SBFI and image analysis fluorescence microscopy as a reflection of Na⁺ transport across the apical membrane of the CCD during luminal addition of Ang II or its precursor. With imaging and rhodamine-conjugated PNA fluorescence characteristics, we could easily differentiate principal and intercalated cell populations in the rabbit CCD.²⁰ In a previous study with photometry, both the change in [Na⁺]_i and the rate of increase ([Na⁺]/t) in CCD cell [Na⁺]_i with Ang II were measured.¹⁶ Nevertheless, previous work as well as the current studies both show that Ang II, when given into the tubular fluid, directly increases Na⁺ transport in the CCD. The current studies extend this finding by localizing the effects of Ang II on Na⁺ transport to principal cells and not to intercalated cells.

In the current studies, luminal Ang I (10^-6 mol/L) increased [Na⁺]_i in principal cells similar to what was obtained with Ang II (10^-9 mol/L; Figures 1B and 2). The 3 orders of magnitude higher concentration of Ang I, compared with that of Ang II, was chosen to provide enough substrate to the convertases to produce Ang II in effective amounts. The similarity of responses evoked by Ang II at nanomolar and Ang I at micromolar concentrations might suggest that only a small fraction of Ang I was converted to Ang II in our system. However, precise estimates of conversion efficacy should not be drawn from the aforementioned data. Consistent with what has been reported for Ang II, the ENaC blocker benzamyl (10^-7 mol/L) nearly abolished the effect of Ang I on principal cell [Na⁺]_i but had no effect on [Na⁺]_i in intercalated cells (data not shown). These results further support the conclusion that Ang II increases Na⁺ transport in the CCD via stimulation of ENaC. In other studies, the effect of luminal Ang I on principal cell [Na⁺]_i was inhibited by the AT₁ receptor blocker losartan. Again these results are consistent with our previous study that suggested a role for AT₁ receptors in mediating the effects of Ang II on ENaC.

Therefore, these data strongly support the view that Ang I exerts its effect on ENaC through apical AT₁ receptors by conversion of Ang I to Ang II. To further test this hypothesis, we sought to characterize the enzymatic activities responsible for Ang I conversion. With angiotensinogen from the proximal tubule and renin from the connecting tubule, the CCD could then be a site for the production of Ang I and the possible conversion to Ang II. ACE is reported to be secreted in the collecting duct and was identified immunologically along the whole length of swine nephron.²¹ Besides observing the highest concentration of ACE in the brush border of proximal tubules (data not shown), we confirmed its presence in the cytoplasm of tubular cells in rabbit CCD and found increasingly strong staining at the apical membrane toward the corticomedullary boundary (Figure 4). ACE does convert Ang I to Ang II, but it might influence other processes as well. For instance, ACE (kininase II) might also degrade bradykinin in the distal nephron. However, bradykinin does not appear to affect Na⁺ transport in the rat CCD.²² In our studies, captopril, which inhibits ACE, was added to the tubular lumen in the presence of Ang I. We found an 50% reduction in Ang I–enhanced Na⁺ influx in principal cells (Figure 3A), suggesting that intraluminal or apical membrane ACE is responsible for the conversion of Ang I to Ang II in the CCD.

Glandular kallikrein is also capable of converting Ang I to Ang II, and this enzyme is insensitive to captopril.²³ Similar to ACE, kallikrein is reported to be expressed and secreted in the CCD, and this occurs mainly in cortical segments. Aprotinin is a widely used though not entirely specific blocker of glandular kallikrein. Therefore, whereas captopril is a specific blocker of ACE, aprotinin has additional effects besides blockade of glandular kallikrein. For instance, aprotinin might interfere with the actions and secretion of ACE.²⁴ However, in swine kidney, ACE secretion is not influenced by aprotinin.²⁵ In our studies, there was also a 50% inhibition of [Na⁺]_i elevation in principal cells on addition of aprotinin and Ang I to the tubular lumen. Thus both inhibitors, captopril and aprotinin, appear to be active in the lumen and/or at the apical membrane of CCD cells, and both appear to block, at least to some extent, conversion of Ang I to Ang II. Simultaneous addition of both captopril and aprotinin appeared to further reduce the stimulatory effects of Ang I on principal cell [Na⁺]_i, although the effects of both agents together did not achieve statistical significance compared with either agent alone. It should be noted that aprotinin was used to test the effects of another proteinase on Ang I to Ang II conversion. It is possible that the effects of aprotinin occurs through kallikrein; however, it is equally possible that it also blocks ACE or other proteinases. In addition to ACE and possibly kallikrein, other enzymes are also capable of converting Ang I to Ang II, including chymase.⁵ It has been reported that certain proteases (including trypsin and tonin²³) might convert angiotensinogen directly to Ang II, thus bypassing the step of conversion to Ang I. The existence and distribution of the various enzymes that form Ang II, in terms of specific tubular segments, location within defined nephron segments (cortical versus medullary and proximal versus distal, for example), and cellular distribution (apical versus cytoplasmic), might vary among species and with physiologic conditions. Thus, it might not be possible to generalize regarding the exact enzyme or enzymatic process that results in the local generation of Ang II from Ang I in the CCD. Nevertheless, these studies do suggest that conversion of Ang I to Ang II can occur in the lumen of the CCD and that the Ang II that is formed stimulates ENaC activity via activation of AT₁ receptors.

Perspectives
Ang II is not only a vasoactive hormone but also is important in controlling renal tubular salt reabsorption. Recent evidence suggests that the enzymatic components exist in renal tubules that might lead to formation of Ang II. The collecting duct is responsible for determining the final composition of urine, controlling extracellular volume and electrolyte composition, and blood pressure control. This work identified that Ang II can be formed intraluminally in the collecting duct and that this hormone can directly increase sodium reabsorption in this segment. Thus, these studies have identified the existence of a collecting duct–Ang II system that might play an important role in the regulation of collecting duct reabsorptive function, homeostasis, and blood pressure regulation.

	Acknowledgments

 
This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Disease (Bethesda, Md) (32032) to P.D.B. and by grants AHA SDG (0230074N), ASN Carl W. Gottschalk Research Scholar grant and ETT 235 to J.P.P., and OTKA 34409 to L.R. We thank Jane Hosmer at the University of Alabama at Birmingham Histology Division for excellent technical assistance with tissue processing and sectioning.

Received May 1, 2003; first decision May 19, 2003; accepted May 30, 2003.

	References

Top Abstract Introduction Methods Results Discussion References

 

1. Zhuo J, Moeller I, Jenkins T, Chai SY, Allen AM, Ohishi M, Mendelsohn FA. Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2, and AT4 receptors. J Hypertens. 1998; 16: 2027–2037.[CrossRef][Medline] [Order article via Infotrieve]
2. Navar LG, Imig JD, Zou L, Wang CT. Intrarenal production of angiotensin II. Semin Nephrol. 1997; 17: 412–422.[Medline] [Order article via Infotrieve]
3. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, Zhang S, Cheng T, Inagami T, Ward K, Terreros DA, Lalouel JM. Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension. 1999; 34: 1265–1274.[Abstract/Free Full Text]
4. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension. 2002; 39: 316–322.[Abstract/Free Full Text]
5. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart [published erratum appears in J Biol Chem. 1991;266:12114]. J Biol Chem. 1990; 265: 22348–22357.[Abstract/Free Full Text]
6. Arakawa K. Serine protease angiotensin II systems. J Hypertens Suppl. 1996; 14: S3–S7.[Medline] [Order article via Infotrieve]
7. Omata K, Carretero OA, Scicli AG, Jackson BA. Localization of active and inactive kallikrein (kininogenase activity) in the microdissected rabbit nephron. Kidney Int. 1982; 22: 602–607.[Medline] [Order article via Infotrieve]
8. Tomita K, Endou H, Sakai F. Localization of kallikrein-like activity along a single nephron in rabbits. Pflugers Arch. 1981; 389: 91–95.[CrossRef][Medline] [Order article via Infotrieve]
9. Fuller PJ, Funder JW. The cellular physiology of glandular kallikrein. Kidney Int. 1986; 29: 953–964.[Medline] [Order article via Infotrieve]
10. Casarini DE, Boim MA, Stella RC, Krieger-Azzolini MH, Krieger JE, Schor N. Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am J Physiol. 1997; 272: F405–F409.[Medline] [Order article via Infotrieve]
11. Marchetti J, Roseau S, Alhenc-Gelas F. Angiotensin I converting enzyme and kinin-hydrolyzing enzymes along the rabbit nephron. Kidney Int. 1987; 31: 744–751.[Medline] [Order article via Infotrieve]
12. Wei Y, Wang W. Angiotensin II stimulates basolateral K channels in rat cortical collecting ducts. Am J Physiol. 2003; 284: F175–F181.
13. Tojo A, Tisher CC, Madsen KM. Angiotensin II regulates H⁺-ATPase activity in rat cortical collecting duct. Am J Physiol. 1994; 267: F1045–F1051.[Medline] [Order article via Infotrieve]
14. Schlatter E, Haxelmans S, Ankorina I, Kleta R. Regulation of Na⁺/H⁺ exchange by diadenosine polyphosphates, angiotensin II, and vasopressin in rat cortical collecting duct. J Am Soc Nephrol. 1995; 6: 1223–1229.[Abstract]
15. Wang T, Giebisch G. Effects of angiotensin II on electrolyte transport in the early and late distal tubule in rat kidney. Am J Physiol. 1996; 271: F143–F149.[Medline] [Order article via Infotrieve]
16. Peti-Peterdi J, Warnock DG, Bell PD. Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT1 receptors. J Am Soc Nephrol. 2002; 13: 1131–1135.[Abstract/Free Full Text]
17. Satlin LM, Matsumoto T, Schwartz GJ. Postnatal maturation of rabbit renal collecting duct. III. Peanut lectin-binding intercalated cells. Am J Physiol. 1992; 262: F199–F208.[Medline] [Order article via Infotrieve]
18. Peti-Peterdi J, Bebok Z, Lapointe JY, Bell PD. Novel regulation of cell [Na⁺] in macula densa cells: apical Na⁺ recycling by H-K-ATPase. Am J Physiol Renal Physiol. 2002; 282: 324–329.
19. Peti-Peterdi J, Chambrey R, Bebok Z, Biemesderfer D, St John PL, Abrahamson DR, Warnock DG, Bell PD. Macula densa Na⁺/H⁺ exchange activities mediated by apical NHE2 and basolateral NHE4 isoforms. Am J Physiol. 2000; 278: F452–F463.
20. Woda CB, Leite M Jr, Rohatgi R, Satlin LM. Effects of luminal flow and nucleotides on [Ca²⁺]_i in rabbit cortical collecting duct. Am J Physiol. 2002; 283: F437–F446.
21. Hall ER, Kato J, Erdos EG, Robinson CJ, Oshima G. Angiotensin I-converting enzyme in the nephron. Life Sci. 1976; 18: 1299–1303.[CrossRef][Medline] [Order article via Infotrieve]
22. Tomita K, Pisano JJ, Knepper MA. Control of sodium and potassium transport in the cortical collecting duct of the rat: effects of bradykinin, vasopressin, and deoxycorticosterone. J Clin Invest. 1985; 76: 132–136.[Medline] [Order article via Infotrieve]
23. Ideishi M, Sasaguri M, Ikeda M, Arakawa K. Angiotensin-converting activity of tissue kallikrein. Nephron. 1990; 55 (suppl 1): 62–64.[Medline] [Order article via Infotrieve]
24. Naim HY. Secretion of human intestinal angiotensin-converting enzyme and its association with the differentiation state of intestinal cells. Biochem J. 1996; 316 (pt 1): 259–264.[Medline] [Order article via Infotrieve]
25. Oppong SY, Hooper NM. Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane. Biochem J. 1993; 292 (pt 2): 597–603.[Medline] [Order article via Infotrieve]

This article has been cited by other articles:

				J. Peti-Peterdi, J. J. Kang, and I. Toma Activation of the renal renin-angiotensin system in diabetes--new concepts Nephrol. Dial. Transplant., July 20, 2008; (2008) gfn377v1. [Full Text] [PDF]

				J. J. Kang, I. Toma, A. Sipos, E. J. Meer, S. L. Vargas, and J. Peti-Peterdi The Collecting Duct Is the Major Source of Prorenin in Diabetes Hypertension, June 1, 2008; 51(6): 1597 - 1604. [Abstract] [Full Text] [PDF]

				M. C. Prieto-Carrasquero, F. T. Botros, J. Pagan, H. Kobori, D. M. Seth, D. E. Casarini, and L. G. Navar Collecting Duct Renin Is Upregulated in Both Kidneys of 2-Kidney, 1-Clip Goldblatt Hypertensive Rats Hypertension, June 1, 2008; 51(6): 1590 - 1596. [Abstract] [Full Text] [PDF]

				H. Kobori, A. Katsurada, K. Miyata, N. Ohashi, R. Satou, T. Saito, Y. Hagiwara, K. Miyashita, and L. G. Navar Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1257 - F1263. [Abstract] [Full Text] [PDF]

				N. Picard, D. Eladari, S. El Moghrabi, C. Planes, S. Bourgeois, P. Houillier, Q. Wang, M. Burnier, G. Deschenes, M. A. Knepper, et al. Defective ENaC Processing and Function in Tissue Kallikrein-deficient Mice J. Biol. Chem., February 22, 2008; 283(8): 4602 - 4611. [Abstract] [Full Text] [PDF]

				S. Soodvilai, Z. Jia, and T. Yang Hydrogen peroxide stimulates chloride secretion in primary inner medullary collecting duct cells via mPGES-1-derived PGE2 Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1571 - F1576. [Abstract] [Full Text] [PDF]

				H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287. [Abstract] [Full Text] [PDF]

				A. Katsurada, Y. Hagiwara, K. Miyashita, R. Satou, K. Miyata, N. Ohashi, L. G. Navar, and H. Kobori Novel sandwich ELISA for human angiotensinogen Am J Physiol Renal Physiol, September 1, 2007; 293(3): F956 - F960. [Abstract] [Full Text] [PDF]

				H. Kobori, Y. Ozawa, R. Satou, A. Katsurada, K. Miyata, N. Ohashi, N. Hase, Y. Suzaki, C. D. Sigmund, and L. G. Navar Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice Am J Physiol Renal Physiol, September 1, 2007; 293(3): F938 - F945. [Abstract] [Full Text] [PDF]

				Y. Wei, B. Zavilowitz, L. M. Satlin, and W.-H. Wang Angiotensin II Inhibits the ROMK-like Small Conductance K Channel in Renal Cortical Collecting Duct during Dietary Potassium Restriction J. Biol. Chem., March 2, 2007; 282(9): 6455 - 6462. [Abstract] [Full Text] [PDF]

				J.-M. Lalouel and A. Rohrwasser Genetic Susceptibility to Essential Hypertension: Insight From Angiotensinogen Hypertension, March 1, 2007; 49(3): 597 - 603. [Abstract] [Full Text] [PDF]

				D.-F. Guo, I. Chenier, J. L. Lavoie, J. S.D. Chan, P. Hamet, J. Tremblay, X. M. Chen, D. H. Wang, and T. Inagami Development of Hypertension and Kidney Hypertrophy in Transgenic Mice Overexpressing ARAP1 Gene in the Kidney Hypertension, September 1, 2006; 48(3): 453 - 459. [Abstract] [Full Text] [PDF]

				M. C. Prieto-Carrasquero, H. Kobori, Y. Ozawa, A. Gutierrez, D. Seth, and L. G. Navar AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats Am J Physiol Renal Physiol, September 1, 2005; 289(3): F632 - F637. [Abstract] [Full Text] [PDF]

				M. C. Prieto-Carrasquero, L. M. Harrison-Bernard, H. Kobori, Y. Ozawa, K. S. Hering-Smith, L. L. Hamm, and L. G. Navar Enhancement of Collecting Duct Renin in Angiotensin II-Dependent Hypertensive Rats Hypertension, August 1, 2004; 44(2): 223 - 229. [Abstract] [Full Text] [PDF]

				J. L. Lavoie, K. D. Lake-Bruse, and C. D. Sigmund Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule Am J Physiol Renal Physiol, May 1, 2004; 286(5): F965 - F971. [Abstract] [Full Text] [PDF]

				H. Kobori, M. C. Prieto-Carrasquero, Y. Ozawa, and L. G. Navar AT1 Receptor Mediated Augmentation of Intrarenal Angiotensinogen in Angiotensin II-Dependent Hypertension Hypertension, May 1, 2004; 43(5): 1126 - 1132. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 42/2/195    most recent 01.HYP.0000081221.36703.01v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Komlosi, P. Articles by Bell, P. D. Search for Related Content PubMed PubMed Citation Articles by Komlosi, P. Articles by Bell, P. D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CAPTOPRIL SODIUM Related Collections ACE/Angiotension receptors